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Abstract 
Multidrug resistant (MDR) bacteria complicate therapeutic management and limit treatment options. With the 
increase of antibiotic resistance among bacterial isolates, monitoring of the of drug resistance pattern became 
critical for appropriate empiric selection of antibiotic therapy. Between June 2014 to January 2015, a 
prospective study was carried out in Manmohan Memorial Medical College and Teaching Hospital, Kathmandu 
with an objective to determine the status of Extended Spectrum Beta- Lactamase (ESBL) and Biofilm producing 
MDR bacterial isolates from blood samples. Identification of the isolates was done by standard microbiological 
techniques and antibiotic susceptibility testing was done by Kirby Bauer disc diffusion method following 
Clinical and Laboratory Standard Institute (CLSI) guidelines. ESBL screening of gram negative isolates was 
done using Ceftriaxone, Aztreonam, Cefotaxime, Ceftazidime and Cefpodoxime followed by confirmation using 
MASTDISCSTM Extended Spectrum Beta- Lactamase (ESβL) Detection Discs and Biofilm detection was done 
by Congo-Red and Tube- adherence Method. The culture positivity of 16% and 10 different species of bacteria 
were isolated. The most frequently occurring isolate was Escherichia coli followed by Staphylococcus aureus. 
In vitro antibiotic susceptibility test showed that Amikacin remains the principle antibiotic of choice based on its 
effectiveness on both gram positive and gram negative bacteria.  
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Ninety five percent of isolates were MDR with 77.19% ESBL producers and 72.5% were biofilm producers. A 
statistically significant relationship was found between increasing spectrum of drug resistance and ESBL 
production and drug resistant in biofilm production (p<0.05). 
Keywords: Multidrug resistant; Extended Spectrum Beta- Lactamase; Biofilm 
1. Introduction   
 The presence of viable bacteria in the circulating blood is termed as Bacteremia. Bacteria may enter the blood 
stream giving rise to bacteremia from an existing focus of infection from a site with the commensally flora or by 
direct inoculation of contaminated materials into the vascular system. Bacteremia can occur in daily activities 
like tooth brushing and some minor medical procedures like dental work but also during infection that leads to 
bacteremia [1].  These organisms are often cleared from the blood within minutes, so the bacteremia is silent 
and transient, but if the immune system is overwhelmed or evaded, organisms persist in the blood and 
bacteremic symptoms would arise [2]. Bloodstream infections are potentially life-threatening and require rapid 
identification and antibiotic susceptibility testing of the causative pathogen in order to facilitate specific 
antimicrobial therapy [3]. Bloodstream infections remain one of the most important causes of morbidity and 
mortality worldwide [4]. Despite important progresses in treatment and prevention of infectious diseases, they 
are considered as leading causes of death and disability and worsening life quality especially for millions of 
people in developing countries. Bacteremia can occur in healthy individuals, new born babies, and immune 
compromised individuals such as patients with diabetes millits, solid tumor and leukemia [5]. The incidence rate 
of community acquired bacteremia varies according to the geographical location [6]. Nosocomial blood stream 
infection is leading cause of bacteremia in critically ill patients [7]. The overall incidence of bacteremia has 
being   increasing recently [8, 9, 10]. The poor prognosis and fatal outcomes are associated with septic shock, 
deterioration of mental status, poly microbial bacterimias and having certain underlying conditions such as 
tumors [11, 12]. In particular, Gram- negative organisms are renowned for inducing septic shock, which is often 
followed by sepsis related death. Several groups have reported that the prevalance of Gram- negative bacteria 
has increased among episodes of febrile neutropenic in the hematology units [13]. The most common bacteria 
responsible for the bacteremia are E.coli, Streptococcus pneumonia, and Staphylococcus aureus [14]. 
Bloodstream infections are potentially life-threatening and require rapid identification and antibiotic 
susceptibility testing of the causative pathogen in order to facilitate specific antimicrobial therapy [3]. Bacteria 
isolated from bloodstream infections are numerous [15] and their associated diseases need urgent and invasive 
management with antimicrobial drugs. Both gram positive and gram negative bacteria causes bacteraemia and 
septicaemia. Gram negative septicaemia, also known as endotoxic shock, is more severe than gram positive 
septicaemia. Many septic episodes are nosocomial and may be due to microorganisms with increased 
antimicrobial resistance. Staphylococcus aureus, Escherichia coli, Coagulase-negative staphylococci (CONS), 
Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus spp., Streptococcus spp., Candida albicans, 
and Enterobacter cloacae are the most frequent etiological agents of bactaerimia and fungaemia in Europe and 
the United States [3]. The mortality associated with bloodstream infections may range from 20% to 50% and 
depends on several factors, including the pathogen and host [16]. It is estimated that 2 million patients per year 
in the United States acquire infections while in hospitals, approximately 350,000 (10-20%) of these infections 
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involve the bloodstream, and 90,000 (4.5%) are fatal. In Nepal, febrile illness is one of the most common 
reasons for medical consultation. The etiology of bloodstream infection in febrile patients is poorly 
characterized in Nepal, mainly due to limited laboratory resources, a poor recording system and an inadequate 
number of trained personnel [17]. 
1.1 The effect of antimicrobials and the problem of drug resistance 
Multi drug resistance is defined as the resistance to at least two classes of first line agents including 
Ampicillin,Chloramphenicol, Trimethoprim-Sulfamethoxazole, Fluroquinolones (Ciprofloxacin and Ofloxacin), 
and Cephalosporins (Cefotaxime, Ceftriaxone and Ceftazidime) [18].The overuse and misuse of the 
antimicrobials have led to the death of the sensitive strains leaving resistant strains to survive, multiply and 
infect new hosts. Multidrug resistance is now commonly described among isolates of streptococcal, 
staphylococcal, and enterococcal species. Increasing drug resistance has occurred among “community-acquired” 
isolates such as HACEK microorganisms, Salmonella spp and Enterobacteriaceae, as well as among nosocomial 
isolates such as Pseudomonas spp [19]. The increasing incidence and prevalence of methicillin resistant S. 
aureus (MRSA) and the emergence of community-associated MRSA (CA-MRSA) is an important challenge for 
clinicians when treating S. aureus bacteremia [20]. Although first identified just >4 decades ago, methicillin-
resistant S.aureus (MRSA) has undergone rapid evolutionary changes and epidemiologic expansion to become a 
major cause of nosocomial and community-acquired infections worldwide. Increasing resistance to vancomycin 
among MRSA strains in conjunction with availability of new antibiotics, including daptomycin and linezolid, 
have increased treatment choices but made clinical treatment decisions more challenging [21]. Βeta lactamases 
are the most common cause of bacterial resistant to β lactam antimicrobial agents which are used in the 
treatment of infections caused mainly by bacteria belonging to Enterobacteriaceae, Haemophillus spp and 
Neisseria spp. The ability of β- lactamases to cause resistance varies with its activity, quantity, cellular locations 
and permeability of the producer strain. Bacteraia responded with plethora of new β- lactamases including 
extended spectrum  β- lactemases(ESBLs), plasmid mediated AmpC β- lactamases and carbapenem hydrolyzing 
β- lactamases (carbapenemases) [22, 23]. Extended spectrum β- lactamases (ESBLs) is defined as the β- 
lactamases that are capable of conferring bacterial resistance to the penicillins, first, second and third generation 
Cephalosporina and Azetreonam (but not the Cephamycins or Carbapenems) by hydrolysis of these antibiotics, 
and which are inhibited by β- lactamases inhibitors auch as Clavulanic acid. The first of these enzymes capable 
of hydrolyzing the newer β- lactams, SHV-2 was found in a single strain of Klebsiella ozaenae isolated in 
Germany. These ESBLs enzymes are produced frequently by E.coli, and Klebsiella spp but other bacteria like 
Enterobacter spp, Salmonella spp, Citrobacter spp and Pseudomonas also produce ESBLs [26, 25]. Thus, rapid 
and reliable detection of bloodstream infections, including characterization of the pathogen to the species level 
and determination of its antibiotic susceptibility pattern, is crucial for several reasons:  
• Appropriate antimicrobial agents can be selected, and thus, unnecessary treatment     with ineffective 
antibiotics can be avoided        
•  The prognosis of the patients can be improved  
•  The acquisition of resistance in pathogens may be decelerated  
•  Expenditure on antimicrobials and overall hospital costs can be reduced [26, 27]. 
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This study could be a guideline for physicians in order to administer proper antibiotics prior to obtaining blood 
culture reports. This study may also help as a guideline for the treatment of patients in the developing countries 
where the most of the health intuitions do not have good culture equipments and sensitive facilities.           
1.2 Biofilm 
Biofilm is defined as microbial sessile aggregation characterized by cells that are irreversibly attached to a 
substratum that may be living or non-living surfaces, enclosed within a self-produced extracellular matrix [28]. 
The matrix is composed of polysaccharides, proteins, and extracellular microbial DNA, and the biofilm may 
consist of one or more microbial (bacterial or fungal) species. The matrix is responsible for  providing structural 
stability and protection to the biofilm against adverse environmental conditions, such as, host immunological 
system and antimicrobial agents[29]. It is a survival strategy that most microorganisms in the environment 
employed for the survival in the hostile environment that might be natural, industrial or even within living hosts. 
Its formation is triggered by specific environmental factors, such as nutrient and oxygen availability [30, 31]. 
Biofilm is estimated to have contribution to more than 80% of human infections [32]. and are source of 
persistent infections caused by various pathogenic microbes [33]. All microbes including Gram positive and 
Gram negative bacteria are capable of synthesizing biofilm. Bacteria commonly involved include 
Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus viridans, Escherichia coli, Enterococcus 
faecalis Klebsiella pneumoniae, Acinetobacter spp, Enterobacter spp Proteus mirabilis and Pseudomonas 
aeruginosa [31]. 
 In biofilm involved infections, bacteria adhere to biotic or abiotic surface, whichever is accessible and form 
bacterial communities, initially microcolonies which later on mature to resistant biofilms [30]. The biofilms are 
resistant to host immune responses as well as antibiotic treatment. As a result, the infections are difficult to 
resolve and tend to be chronic [33]. Biofilm has proved to be nuisance in the management of diseases especially 
those which are device related and thus has gained utmost importance in the medical field [29]. 
1.2.1 Biofilm and Antimicrobial Resistance  
Biofilms are highly resistant to antimicrobial agents (antibiotics, disinfectants or germicides) [28]. 
Antimicrobial resistance exhibited by biofilm is conferred to delay penetration of antimicrobial agents across the 
biofilm matrix i.e. EPS, altered growth rate and other physiological changes due to the biofilm mode of life [30]. 
Biofilm matrix acts as an efficient barrier to antimicrobial agents either by decreasing the transport of these 
agents to interior of biofilm or by reacting with the agents itself [34]. 
Biofilms impose a serious threat in clinical settings due to their involvement in chronic and recurrent infections 
and their higher antimicrobial resistance [33, 35]. Biofilm-involved infections impose a great problem, because 
biofilm-associated bacteria are able to withstand host immune defenses, antibiotics, biocides, and hydrodynamic 
shear forces better as compared to the corresponding planktonic bacteria, thus, making biofilm-associated 
infections particularly recalcitrant to standard antimicrobial treatment as well as host immune counterattacks, 
and  even after the treatment, the surviving biofilm-associated bacteria will carry on the infection [32]. Biofilms 
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may also be responsible for spread of antibiotic resistance via horizontal gene transfer or quorum sensing [33].  
2. Methodology 
2.1 Study site, study duration and study population 
The study was conducted in Manmohan Memorial Medical College and Teaching Hospita (MMMCTH), 
Kathmandu, Nepal from June 2014 to January 2015.  
2.2 Study Population 
Study was conducted on patients visiting MMMCTH for requesting of blood culture and antibiotic susceptibility 
test by the physicians.  
2.2.1 Sample size and sample type 
A total of 500 blood samples were included in the study 
2.2.2 Inclusion and Exclusion Criteria 
Labeled blood cultures with correct patient’s information sheet were included in the study. The blood culture 
bottle were rejected if it is cracked or broken or the media was turbid prior to sample inoculation.  
2.3 Laboratory analysis 
2.3.1 Blood specimen collection, transportation and analysis 
The blood samples were collected by trained health professional using standard aseptic techniques. About 5ml 
of blood from adult and 3ml of blood from children were collected aseptically and inoculated into brain heart 
infusion (BHI) broth. Inoculation of blood sample into the culture broth was done immediately after collection. 
Immediately, after the blood culture bottles were received in the laboratory, they were provided with laboratory 
identification numbers and further processed. The culture bottles were incubated at 370c for 7 days and sub-
cultured at 42 hours, 48 hours or unless the visible growth was obtained. Details on clinical history, age, sex, 
etc. of the patients were recorded after taking informed consent (Appendix I). 
2.3.2 Subculture from broth culture 
The broth cultures were sub-cultured on Nutrient Agar (NA), Mac Conkey Agar (MA) and  Blood Agar(BA) 
plates. .The plates were then incubated at 37°C for 24 hours and readings were being done at 48 hours of 
incubation. For cultures that showed positive bacterial growth, identification of culture isolates was done by 
colonial characteristics, gram stain and biochemical tests according to the standard methods [38].                   
 2.3.3 Identification of the isolates 
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The gram positive organism was identified primarily on the basis of their response to gram’s staining, catalase, 
oxidase and coagulase tests. The gram negative isolates were identified by standard diagnostic procedure as: For 
lactose fermenters, media inoculation for motility, indole production and citrate utilization tests were carried out 
and incubated overnight. Individual colonies of clinically significant, lactose fermenters were inoculated into 2 
ml of urea broth and incubated for 4 hours at 37oc. Any urease positive was then check for purity. The 4 hours 
suspension would serve as the inoculums for biochemical tests for strains of other genera, and purity check on 
Mac Conkey agar. The Gram-staining procedure is mentioned in the Appendix-II. The procedure for performing 
biochemical tests are mentioned in Appendix-III. 
2.3.4 Antimicrobial susceptibility testing 
2.3.4.1 Antibiotic susceptibility test of bacterial isolates 
Antibiotic susceptibility testing of bacterial isolates was done by Kirby Bauer disc diffusion method [40] using 
Muller Hinton Agar. The inoculum was prepared by direct colony suspension method by transferring several 
isolated pure colonies from fresh non-selective agar plate to normal saline. The mixture was vortexed well and 
turbidity was adjusted visually with sterile normal saline to match a 0.5 Macfarland standard. The suspension 
was then swabbed uniformly over entire surface of a sterile MHA plate. With a sterile forcep, selected 
antibiotics discs were placed on inoculated plate no closer than 15 mm from the edge and 24 mm from center of 
discs. The plates were then left at room temperature for 15 minutes for prediffusion and then incubated at (35-
37)0C. On the basis of zone-size compared with that of control strains, the result was interpreted [39] based on 
standard interpretative chart provided by manufacturer was done.  
2.3.4.2 Methicillin resistant Staphylococcus aureus (MRSA) and S. epidermidis (MRSE) Screening 
S. aureus and S. epidermidis were screened for methicillin resistance by modified Kirby Bauer disc diffusion 
method using Oxacillin disc (1 mcg) as per the standard guidelines [40]. 
2.3.4.3 Determination of multidrug resistance in bacterial isolates  
The isolates were defined as multidrug resistant if they were resistant to two or more class of antibiotics tested 
[41]. 
2.3.4.5 List of antibiotics used for susceptibility test  
For Gram Positive cocci: Azithromycin(30μg), Amikacin(30μg), Clindamycin(10μg), Cefixime(5 mcg) , 
Ciprofloxacin(5μg), Cloxacillin(5μg), Ceftriaxone(30μg),Cefotaxime(30mcg), Ceftazidime(30μg), 
Cotrimoxazole(25μg),Chloramphenicol(30 mcg),Erythromycin(15mcg), Gentamicin(10μg),Mupirocin(5 mcg), 
Penicillin G(10μg),Tegecyclin(10mcg), Oxacillin(5μg), Vancomycin(30μg) , 
For Gram Negative bacilli: Amikacin(30μg), Amoxicillin(30 mcg), Ciprofloxacin(5μg), Ceftriaxone(30μg), 
Ceftazidime(30μg), Cotrimoxazole(25μg), , Cefepime(30 mcg), Cefpodoxime(10mcg), Chloramphenicol(30 
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mcg), Cefixime(5mcg), Tigecycline(10 mcg) , Imipenem (10 mcg) Nalidixic Acid(30 mcg), Nitrofurantoin(100 
mcg), Norfloxacin(10 mcg), Gentamycin(10 mcg), Ofloxacin(5 mcg), Piperacillin/Tazobactam(100/10 mcg), 
Gentamicin(10μg), Meropenem(10μg), Ofloxacin(5μg), 
2.3.5 Preservation of the MDR isolates 
After performing the antimicrobial susceptibility testing, MDR isolates in pure culture were preserved in 20% 
glycerol containing Trypic Soya Broth and kept at -4oc for the detection of ESBL and Bio film production test. 
2.3.6 Screening and confirmation for ESBL producers 
Screening of the suspected ESBL strains was performed according to the guidelines for screening issued by the 
CLSI in 2005. According to this guidelines MDR isolates were screened for possible ESBL production using 
Ceftriaxone (30µg), Cefotaxime (30 µg), Cefpodoxime (10µg), Ceftazidime (30µg) and Aztreonam(30µg) and 
the isolates showing zone of inhibition to Ceftriaxone≤25mm , Cefotaxime≤27mm, Cefpodoxime≤17mm, 
Ceftazidime≤22mm,and Aztreonam≤27mm are possible ESBL producers. The suspected ESBL producers were 
tested for confirmatory ESBL production using MASTDICTM Extended Spectrum Beta- Lactamase Detection 
Discs. The kit consists of: 
Set 1: Ceftazidime(30µg) and Ceftazidime(30µg) plus Clavulanic acid(10µg) 
Set2: Cefotaxime (30 µg) and Cefotaxime (30 µg) plus Clavulanic acid(10µg) 
Set 3: Cefpodoxime (10µg) and Cefpodoxime (10µg) plus Clavulanic acid(10µg) 
Set 4: Aztreonam(30µg) and Aztreonam(30µg) plus Clavulanic acid(10µg) 
The zone of inhibition for the Ceftazidime, Cefotaxime, Cefpodoxime was compared to that of these discs 
combined with Clavulanic acid and an increase in zone diameter of ≥ 5mm in the presence of Clavulanic acid 
from any or all of the kit was concluded as confirmed ESBL producers. The detailed working protocol is 
described in Appendix IV. 
2.3.7 Detection of Biofilm Production 
Biofilm production was estimated qualitatively for all the isolates by tube adherence method [42] and Congo- 
red Method [37]. 
Tube Adherence Method (TA) 
Suspension of tested strains was incubated in the glass tubes containing Brain Heart Infusion Broth (BHI) 
aerobically at the temperature of 35°C for the period of 2 days. Then the supernatant was discarded and the glass 
tube was stained by 0.1% safranin solution, washed with distilled water 3 times and dried. A positive result is 
defined by the presence of a layer of stained material adhered to the inner wall of the tubes. The exclusive 
observation of a stained ring at the liquid-air interface should be considered negative. 
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Congo Red Agar Method (CRA)  
The medium composed of Brain heart infusion broth (37 gm/l), sucrose (5gm/l), agar number 1 (10 gm/l) and 
Congo red dye (0.8 gm/l). Congo red stain was prepared as concentrated aqueous solution and autoclaved at 121 
C for 15 minutes. Then it was added to autoclaved Brain heart infusion agar with sucrose at 55 C. Plates were 
inoculated with test organism and incubated at 37 C for 24 to 48 hours aerobically. Black colonies with a dry 
crystalline consistency indicated biofilm production; weak producers usually remained pink, though occasional 
darkening at the centre of colonies was observed. 
Table 1: Pattern of bacterial isolates according to the gram stain 
Bacteria Frequency Percentage 
Gram Negative rods 61 76.25% 
E.coli 30 37.5% 
Salmonella Paratyphi A 14 17.5% 
Salmonella typhi 4 5% 
Proteus mirabilis 1 1.25% 
Proteus vulgaris 3 3.75% 
Klebsiella pneumonia 1 1.25% 
Klebsiella oxytoca 1 1.25% 
Pseudomonas aeruginosa 3 3.75% 
Citrobacter fruendii 4 5% 
Gram positive cocci 19 23.75% 
 Staphylococcus aereus 15 18.75% 
 CONS 4 5% 
   
                 Total                                                                 80                                       100% 
 
2.4 Quality control  
To obtain reliable microbiological result, it is necessary to maintain quality control. Quality of each test was 
maintained by using standard procedures. Control strains of E. coli (ATCC 25922) and Staphylococcus aureus 
(ATCC 25923) were used for the standardization of the Kirby-Bauer test and also for correct interpretation of 
zone of diameter. Quality of sensitivity tests was maintained by maintaining the thickness of MHA at 4 mm and 
the pH at 7.2-7.4. Similarly antibiotics discs containing the correct amount as indicated were used. Strict aseptic 
conditions were maintained while carrying out all the procedures. 
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2.5 Statistical analysis 
The results were expressed as percentages for the analysis of various epidemiological details and for analysing 
the distribution of different bacterial isolates and their sensitivity pattern. Microsoft excel and Chi square test 
was used for the interpretation of these results. 
3.  Results 
3.1 Rate of bacteremia                                              
All together 500 blood samples were collected during the study period and subjected to bacterial cultures in 
which growth was seen only in 80 cases (16%). Four hundred twenty cases were found to be no growth on 72 
hours of incubation at 370C.  
3.2 Pattern of bacterial isolates 
Out of 80 isolated bacteria, 61(76.25%) were gram negative and 19(23.75%) were gram positive. The most 
frequently occurring gram negative isolate was E.coli with (37.5%) and gram positive isolate was S. aureus with 
(18.75%). Results are shown in table 1. 
3.3 Antibiotic susceptibility pattern of gram positive isolates. 
Table 2:  Antibiotic susceptibility pattern of gram positive isolates. 
Antibiotics used Sensitivity pattern of  S.aureus Sensitivity pattern of CONS 
   
 Sensitive   Resistant Sensitive Resistant 
 No. % No. % No.   % No. % 
         
Clindamycin         3 20 12 80                        3  75 1 25 
Cefotaxime            1 6.67 14 93.33 3  75 1 25 
Cloxacillin               0 - 15 100 0 - 4 100 
Vancomycin             12 80 3 20 3  75 1 25 
Erythromycin           3 20 12 80 4 100 0 - 
Gentamycin              12 80 3 20 4 100 0 - 
Penicillin                  1 1.67 14 93.33 0 - 4 100 
Co-Trimoxazole       1 1.67 14 93.33 3 75 1 25 
Mupirocin                 3 20 12 80 0 - 4 100 
Ceftriaxon              2 13.33 13 86.66 3 75 1 25 
Chloramphenicol    9 60 6 40 4 100 0 - 
Oxacillin                 1 6.67 14 93.33 0 - 4 100 
Amikacin                15 100 0 - 4 100 0 - 
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Tigecyclin                6 40 9 60 4 100 0 - 
Cefixime                  0 - 15 100 0 - 4 100 
Ciprofloxacin     10 66.67 5 33.33 4 100 0 - 
Azithromycin       15 100 0 - 4 100 0 - 
Novobiocin * * * * 3 75 1 25 
Polymyxin B 
Fusidic acid                                                       
* 
*
* 
*
* 
* 
* 
* 
4 
0 
100 
- 
0 
4 
- 
100 
* denotes antibiotics not used. 
 
3.4 Methicillin resistance in staphylococci  
Pattern of methicillin resistance in staphylococci was studied. Out of 19 isolates 18 were resistant to methicillin 
as determined by Oxacillin (1mcg) disk by Kirby Bauer disk diffusion method. Among 15 S. aures, 14 (93.33%) 
were resistance to methicillin (MRSA) and among 4 CONS 4(100%) were resistant to methicillin (MRSE).  
Table 3: Methicillin resistance pattern among staphylococci 
S.N.  Staphylococcus  Methicillin  
 spp. (N=19)  Resistant n (%)  
   
1  
2  
S. aureus(15)  
CONS(4)  
14(93.33)  
4(100.0)  
 
3.5 Antibiotic Susceptibility pattern of the gram negative isolates 
Table 4: Antibiotic Susceptibility pattern of the gram negative isolates 
Resistance to 
antibiotics 
used(%) 
                                       Isolates Identified 
 
E.coli 
 
Salmonella 
  Sps 
 Klebisella      
     Sps 
Pseudomonas 
aeruginosa 
Citrobacter 
Sps 
Proteus 
Sps 
 
      
AMK 0 0 0 0 0 2(50) 
AMX          28(93.33) 18(100) 2(100) 3(100) 3(75) 3(75) 
CPM        18(60) 9(50) 0 2(66.67) 2(50) 3(75) 
CTR 14(46.67) 12(66.67) 2(100) 2(66.67) 2(50) 3(75) 
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CPD 16(53.33) 9(50) 0 3(100) 3(75) 3(75) 
C 0 6(33.33) 2(100) 2(66.67) 1(25) 2(50) 
CFM 22(73.33) 13(72.22) 2(100) 2(66.67) 4(100) 3(75) 
TGC 2(6.67) 6(33.33) 0 2(66.67) 1(25) 2(50) 
IPM 1(3.33) 0 0 0 0 2(50) 
NA 6(20) 7(38.89) 2(100) 3(100) 0 2(50) 
NIT 7(23.33) 0 0 1(33.33) 1(25) 1(25) 
NX 0 0 0 2(66.67) 0 1(25) 
GEN 3(10) 0 0 2(66.67) 0 2(50) 
OF 2(6.67) 0 0 2(66.67) 0 2(50) 
PIT 3(10) 0 0 0 0 3(75) 
Note: The antibiotics written in short forms: AMK-Amikacin, AMX–Amoxicillin, CPM-Cefepime, CTR-
Ceftriaxone, CPD- Cefpodoxime, C-Chloramphenicol, CFM-Cefixime, TGC - Tigecycline ,IPM- Imipenem  
NA-Nalidixic Acid, NIT-Nitrofurantoin, NX-Norfloxacin, GEN-Gentamycin, OF-Ofloxacin, PIT-
Piperacillin/Tazobactam 
3.6 MDR and ESBL Production profile among isolates 
Of 80 isolates, 76(95%) were MDR. All the gram positive isolates and 57 out of 61(93.44%) of gram negative 
isolates were found to be MDR. The gram negative isolates are tested for ESBL production among which 44 out 
of 61(72.13%) are ESBL producers. 
Table 5: MDR and ESBL Production profile among isolates 
Organisms Total 
Isolates 
  No.of       
MDR 
ESBL 
Screening 
ESBL   
Confirmed 
Escherichia coli 30 29 30 20 
Salmonella spp. 18 15 18 14 
Klebsiella spp. 2 2 2 1 
Pseudomanas aeruginosa 3 3 3 3 
Citrobacter freundii 4 4 4 3 
Proteus spp 4 4 4 3 
Total 61 57(93.44%) 61 44 
3.7 Bio film production by Congo red method and Tube adherence Method 
 A total of 58 isolates were biofilm producers. Congo red method results 20 weak and 38 strong biofilm 
producers whereas Tube adherence method results 24 weak and 34 strong biofilm producers. 
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Table 6: Bio film production by Congo red method and Tube adherence Method 
Organisms Congo-Red Method Tube adherence Method Total biofilm 
Producer 
    
 
S.aureus 
Weak  Strong Weak Strong  
9 1 7 3 10 
CONS 1 2 1 2 3 
E.coli 5 18 10 13 23 
Salmonella spp 2 12 3 11 14 
Klebsiella spp 0 1 0 1 1 
Citrobacter spp 1 1 1 1 2 
Proteus spp 1 2 1 2 3 
Pseudomonas 
aeruginosa 
1 1 1 1 2 
      
Total 20 38 24 34 58 
3.8 Distribution and biofilm production of isolates 
Among 80 isolates, 58 (72.5%) were biofilm producers by Tube adherence and congo-red method. The majority 
of organisms were associated with the biofilm production. Results are shown in table 7. 
Table 7: Distribution and biofilm production of isolates 
Isolates Total (%) Biofilm 
production 
   
Staphylococcus  aureus 15 (18.75%) 10(66.67%) 
CONS 4 (5%) 3 (75%) 
Escherichia coli 30 (37.5%) 23 (76.67%) 
Salmonella sps 18 (22.5%) 14 (77.78%) 
Klebsiella sps 2 (2.5%) 1(50%) 
Citrobacter freundii 4 (5%) 2 (50%) 
Proteus sps. 4 (5%) 3 (75%) 
Pseudomonas aeruginosa 3 (3.75%) 2 (66.67%) 
   
Total 80 (100%) 58 (72.5%) 
   
3.9 Biofilm production in ESBL producers 
Among 61 gram positive isolates, 44(72.13%) isolates were ESBL producers. Of 44 ESBL producers 
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37(84.09%) were biofilm producers. Detail results are shown in table 8. 
Table 8: Biofilm production in ESBL producers 
Isolates ESBL producer Biofilm producer(%) 
   
Escherichia coli 20 18 (90%) 
Salmonella sps 14 12 (85.71%) 
Klebsiella sps 1 1 (100%) 
Citrobacter freundii 3 2 (66.67%) 
Proteus sps. 3 1 (33.33%) 
Pseudomonas aeruginosa 3 3 (100%) 
   
Total 44 37 (84.09%) 
   
4. Discussion 
The rate of Bacteremia reported in the present study is similar to the findings of other investigators elsewhere in 
the world [43, 44, 45]. However the marked difference in the rate has been reported by many investigators in 
compare to the present study [46, 47, 48, 49, 50]. Different investigators reported different evidences for the 
variation of the results. The prior use of antibiotics has markedly decrease the rate of bacteremia [58].In 
addition, the technique of blood culture, anaerobic infection and effective control in spread of nosocomial 
infection [45]. The low isolation rate is common in developing countries mainly because of prior and haphazard 
use of antibiotics before blood collection for culture [51, 52] as availability and misuse of antibiotics even for 
mild cases of fever in Nepal [53, 54]. The isolation rate of pathogens is as high as 30-70% in well equipped 
laboratories in developed countries where diagnosis system is well established and medication is proper [55]. 
During our study period, only monomicrobial infection, not the polymicrobial infection was found. Mono 
microbial bacteremia most prevalent (97.5%) than polymicrobial bacteremia[56]. Our study showed that the 
gram negative isolates were predominant cause of blood stream infection over gram positive isolates which was 
similar as reported in [57].  
Our study showed that E.coli to be the causative agent of bacteremia. [43, 58] also reported high percentage of 
isolation of E.coli from blood. The high prevalence of Salmonella spp in bloodstream isolates in febrile patients 
in our study corresponds to the findings of previous studies performed in Nepal [59, 60, 61]. Similarly, high 
prevalence of S.aureus in this study is similar to the studies done on blood stream infection [62]. CONS had 
been reported as the most common organism from blood culture isolates from different studies [63]. The present 
study isolated 5% of the CONS. The clinical significance of CONS when isolated from blood cultures should 
always be evaluated. Some studies have reported that upto 85% of CONS represent contamination rather than 
true bacteremia [64]. However, in recent years, CONS have become an important nosocomial pathogen partly 
because of the increasing use of medical devices such as long term indwelling catheters, vascular grafts, and 
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prosthetic heart valves and joints [65]. Present study excluded Bacillus spp. and Micrococcus spp. as a 
contaminant but finding of this microorganism must be reported if patients had suspected endocarditis or in 
immunocompromised [66]. 
Antibiotic susceptibility testing has become a very essential step for the proper treatment of the infectious 
diseases. The result of present study suggest Amikacin remains the principle antibiotic of choice based on its 
effectiveness on both gram positive and gram negative bacteria which is according to [46] who also reported 
Amikacin effective against both gram negative and gram positive isolates. Our results on antibiotics 
susceptibility pattern of gram negative isolates is comparable to the study conducted in [50, 17, 57].  
Our study finds, Amikacin and Azithromycin to be the most effective for S. aureus but Cloxacillin, 
Clindamycin, Penicillin, Oxacillin, Cefixime, Co- trimoxazole were ineffective. Resistance of S. aureus to most 
of the commonly used antibiotics ranged from 60% to 90% [67]. On similar type of studies conducted in [66] 
Vancomycin, Amoxicillin, Clindamycin and Ciprofloxacin have optimum activities against Staphylococci 
whereas Cloxacillin was found least active. Similarly, High rates of antibiotic resistance was seen among 
 CONS to commonly-used antibiotics and majority of them were methicillin-resistant [68]. Our study also 
reports CONS resistant towards Oxacillin, Fusidic acid, Penicillin and Mupirocin. [69] also reports 100% 
resistant to penicillin and ampicillin but [69] reported the highest number were resistant to oxacillin (94.5%) 
followed by  Gentamycin(40%). 
Already a major cause both of nosocomial and community infections, S. aureus has reached endemic 
proportions with the worldwide emergence of antibiotic-resistant strains. The introduction of MRSA has 
increased the morbidity and mortality associated with bacteremia and endocarditis and has significantly reduced 
the standard therapeutic options [21]. In present study a large proportion of staphylococal isolates were resistant 
to methicillin which is consistent to the study of [70] who reported high prevalence of Methicillin and 
Vancomycin resistant S. aureus in Sikkim. Various other studies have also reported high prevalence of MRSA 
in hospital and community acquired infections [67]. 
The increasing incidence of MRSA infection is a serious problem in patient management as therapeutic options 
are limited for such resistant strains. Vancomycin is a drug of choice for the treatment of MRSA infection [71] 
[72]. However, tolerance to vancomycin among MRSA is on rise. Therapy with vancomycin is associated with a 
long duration of bacteremia on therapy and relapses [73]. An elevated vancomycin MICs for MRSA isolates 
was reported elsewhere [74].In our study, 80% of isolates were sensitive to Vancomycin. Daptomycin as an 
alternative to vancomycin in the therapy of S. aureus bacteremia and endocarditis for those with either 
methicillin-resistant organisms or intolerance to beta-lactams has been suggested by studies [21, 73]. But 
treatment failure even with vancomycin and daptomycin has also been reported [75]. Therapy with linezolid and 
fusidic acid was successful in clearing MRSA bacteremia [75]. 
Among the isolates of E. coli, Amikacin, Chloramphenicol, Imipenem, Tigecycline, Ofloxacin Nalidixic acid, 
Gentamycin and Piperacillin/Tazobactam were found to be the most effective drug where as Amoxicillin is least 
effective. This result is comparable to the study conducted in [76]. They found Amikacin, Chloramphenicol, 
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Imipenem, Nitrofurantoin to be most effective drug against E.coli isolates and also reported the presence of high 
resistant rates for different classes of antibiotics. In Salmonella species, Amikacin, Imipenem, Nitrofurantoin, 
Gentamycin, Ofloxacin,Piperacillin/Tazobactam were found to be effective with 100% sensitivity and 
Amoxicillin is uneffective. [77, 78] also reported 100% susceptible of Salmonella towards Ofloxacin. 
 It is neither possible nor desirable to specify drug of choice by seeing only the resistant pattern because 
specification of drug of choice depends upon the several factors like differences in local prescribing habits, 
resistant pattern of local pathogens, cost, toxicity, pharmacokinetics and spectrum of activity of antibiotics [79]. 
Antimicrobial resistance is a global problem. It is now generally accepted as major public health issue and has 
significant implication on health and patient care. Resistance to antimicrobial drugs is associated with high 
morbidity and mortality, high health-care cost and prolonged hospitalization. The problem of the drug resistance 
to antimicrobial drug is more troublesome to developing countries. Our Ninety five percent isolates are MDR 
and these pathogens are more common in hospital setting and are mainly accountable for nosocomial infection. 
Our result is slightly higher than that reported in [44]. However, the incidence of bacteremia caused by MDR 
strain is increasing [80] .The emergence and increasing trend of MDR among E.coli has been also reported [43]. 
The emergence of MDR is clearly related to the quantity of antibiotics and how they are being used [81]. 
Resistant strains are now reported against all available classes of antibiotics [81, 82]. The morbidity and 
mortality rates because of MDR strains among the very young, elderly population and among immuno-
compromised patients are very high [82]. The recent increase of MDR strains in hospital has started to pose 
great difficult in selecting antimicrobial agents for the management of the infection they caused and obviously 
the cost in the management of infection caused by MDR strains will be definitely high because of need of 
acquiring new drug which is of course will be high in cost as well as the cost of prolong staying in the hospital. 
Some factors responsible for the emergence of resistant strains in hospital include the indiscriminate use of 
antibiotics, the prolonged hospitalization, the increase in uses of insertion devices etc [16]. 
Our study reported 77.19% ESBL producers among MDR isolates. [43, 87] reported 69.23% and 62% ESBL 
producers among MDR isolates respectively. Therefore the study highlights the emergence of ESBL producing 
strains endowed with extremely wide spectrum of antibiotic resistant. ESBL production is coded by genes that 
are prevalently located on large conjugative plasmid of 80-160 kb in size. Since these plasmids are easily 
transmitted among different members of the Enterobacteriaceae, accumulation of resistant genes results in 
strains that contain multi-resistant plasmids. So, ESBL producing isolates are resistant to variety of classes of 
antibiotics [84]. Currently, ESBL and AmpC β-lactamase producers are becoming a major threat for patients in 
the hospital, long-term care facilities, and community. These bacteria have not only caused outbreaks, but have 
become endemic in many hospitals throughout the world. In addition, antibiotic resistance of bacteria in the 
biofilm mode of growth contributes to the chronicity of infections such as those associated with implanted 
medical devices [22]. 
A biofilm is a structured consortium of bacteria adhered to a substratum and embedded in a self-produced 
extracellular polymer substance (EPS) consisting of polysaccharide, protein and DNA. Bacterial biofilms are of 
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clinical relevance since they confer resistance to antibiotics and disinfectants, as well as resistance to 
phagocytosis and the host immune system generally, all factors promoting chronic infections. Bio film 
production test in our study is conducted by two methods i.e Tube adherence method (TAM) and Congo red 
method (CRA), which can be indicated for the routine detection of biofilm production.  Tube adherence method 
to be easily applicable, cost effective and it also guarantees reliable results with excellent sensitivity and 
specificity [85]. The CRA method is fast, reproducible, and presents an advantage: the colonies remain viable in 
the medium for further analysis.  The method is easy to carry out and the results are usually based on the colony 
color produced, which ranges from red for non-biofilm–producing strains to black for biofilm-producing strains 
[86]. The CRA method presented 89% sensitivity and 100% specificity when compared to PCR as a standard 
[87]. These phenotypic methods are simple and cost-effective for screening method of biofilm formation and do 
not require technical expertise, which makes it appropriate for laboratory use in a developing country like 
Nepal. Tissue culture plate technique is considered the most reliable method for screening of biofilm. However, 
TCP method was also not used due to the requirement of technical expertise for the use of sophisticated ELISA 
reader to measure density of stained bacterial biofilms adherent to plastic surfaces spectrophotometrically[88]. 
Using these methods, 72.5% of total blood isolates were found to be biofilm producers. It has been reported that 
more than 50% of total human infections are associated with biofilm production [89]. Similar type of studies 
[90] on Enterobacteriaceae showed 59.2% of the tested organisms have shown the potential to make biofilms 
in-vitro. Similarly, 66.67 % of S.sureus isolates in our study have potential to form biofilm in vitro which is 
slightly lower than that reported on [91] and among the CONS isolated 75% were biofilm producers which is 
comparable to [92]. They reported 82% CONS to be biofilm producers. 
In this study, we found that ESBL producing isolates had a higher ability to form biofilm in comparison with 
non-ESBL producing isolates. Our study reported 84.09% of ESBL producers showed biofilm producers which 
is in comparision to [90]. It has been suggested that a number of chromosomal gene rearrangement occurs upon 
acquisition of the ESBL plasmid and higher mortality and severity of infection caused by ESBL producing 
isolates is due to the expression of several virulence genes simultaneously. 
There was significant association of ESBL production and level of multidrug resistance among MDR ESBL 
isolates (p>0.05) and similar results was found on [83, 93]. Similarly, the association between Multi-drug 
resistant and Biofilm producers was found to be statistically significant (p>0.05).   
5. Conclusion 
Blood culture still remains as one of the most important microbiological tests available to the clinician for the 
diagnosis of bacteraemia. The blood culture positivity rate in our study was 16%. The study revealed that the 
gram-negative bacilli predominates the culture positive cases and E.coli are the leading etiological agents 
followed by S.aureus. The isolates showed higher rate of in-vitro susceptibility towards Amikacin for both 
gram-negative and gram- positive isolates. The most of the isolates are MDR and biofilm producers. Increased 
rate of multi drug resistance (including methicillin resistance in staphylococci) is challenging conventional 
therapeutic regimen complicating the management of bacteremia. Resistance to recommended drugs like 
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cephalosporins, aminoglycosides and fluroroqinolones are of major concern and aware the clinicians and the 
health care workers to seek for alternative antimicrobial agents. Our data underscore the need for periodic 
survey of etiological agents and their resistance surveillance reports which can provide valuable insight into 
resistance trends to assist in guidance in the appropriate choice of empiric therapy. Disabling biofilm resistance 
may enhance the ability of existing antibiotics to clear infections involving biofilms that are refractory to current 
treatments. 
6.  Recommendations 
• Resistance to recommended drugs like cephalosporins, aminoglycosides and fluroroqinolones are of major 
concern and aware the clinicians and the health care workers to seek for alternative antimicrobial agents. 
Our data underscore the need for periodic survey of etiological agents and their resistance surveillance 
reports which can provide valuable insight into resistance trends to assist in guidance in the appropriate 
choice of empiric therapy. 
• Disabling biofilm resistance may enhance the ability of existing antibiotics to clear infections involving 
biofilms that are refractory to current treatments. 
7.  Limitations 
As the study conducted in Manmohan Memorial Medical College and    Teaching Hospital does not represent 
whole scenario of country, the surveillance should be carried out through out the year covering wide 
geographical region in order to obtain information regarding variation of pathogen and their antibiotic 
sensitivity profile. 
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APPENDIX-I 
 Questionnaire 
1. Patient’s ID:        Date:                                                  
2. Patient’s name: 
3. Age: 
4. Sex: 
5. Address: 
6. Patient type: OPD/ Emergency/Ward 
 
7. Clinical signs and symptoms: 
Clinical Sign and symptoms Yes No 
Fever   
Abdominal pain   
Headache   
Vomiting   
Cough   
Constipation   
Diarrhea   
Back pain   
Chills and rigor   
Red spots   
 
8. Duration of illness: less than1 week / 1 to 2 weeks / More than 2 weeks 
9. Temperature record: 
10. Prior consultant: 
11. Prior treatment of antibiotics: Yes/No 
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       If yes, name of antibiotic: 
 APPENDIX-II 
A. GRAM-STAINING PROCEDURE 
First devised by Hans Christian Gram during the late 19th century, the Gram-stain can be used effectively to 
divide all bacterial species into two large groups: those that take up the basic dye, crystal violet (Gram-positive) 
and those that allow the crystal dye to was out easily with the decolorizer alcohol or acetone (Gram-negative). 
The following steps are involved in Gram-stain: 
A thin film of the material to be examined was prepared and dried. 
The material on the slide was heat fixed and allowed to cool before staining. 
1. The slide was flooded with crystal violet stain and allowed to remain without drying for 1 minute. 
2. The slide was rinsed with tap water, shaking off excess. 
3. The slide was flooded with iodine solution and allowed to remain on the surface without drying for twice 
as long as the crystal violet was in contact with the slide surface. 
4. The slide was rinsed with tap water, shaking off excess. 
5. The slide was flooded with alcohol acetone decolorizer for 10 seconds and rinsed immediately with tap 
water until no further color flows from the slide with the decolorizer. Thicker smear requires more aggressive 
decolorizing. 
6. The slide was flooded with counter-stain (safranine) for 1 minute and washed off with tap water. 
7. The slide was blotted between two clean sheets of bibulous paper and examined microscopically under 
oil immersion at 100X. 
APPENDIX-III 
METHODOLOGY OF BIOCHEMICAL TESTS USED FOR IDENTIFICATION OF BACTERIA 
A. Catalase test: This test is performed to demonstrate the presence of catalase, an enzyme that catalyses the 
release of oxygen from hydrogen peroxide.During aerobic respiration, in the presence of oxygen, 
microorganisms produces hydrogen peroxide, which is lethal to the cell itself. The enzyme catalase is present in 
most cytochrome containing aerobic and facultative anaerobic bacteria, the main exception being Streptococcus 
spp.  
Procedure: A small amount of a culture from Nutrient Agar plate was taken in a clean glass slide and about 2-3 
drops of 3% H2O2 was put on the surface of the slide. The positive test is indicated by the formation of active 
bubbling of the oxygen gas. A false positive reaction may be obtained if the culture medium contains catalase 
(e.g. Blood Agar) or if an iron wire loop is used. 
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B. Oxidase test: This test is performed for the detection of cytochrome oxidase in bacteria which catalyzes the 
transport of electrons between electron donors. In the presence of redox dye Tetramethyl-p-phenylene diamine 
dihydrochloride, the cytochrome oxidase oxidizes it into a deep purple colored end product Indophenol which is 
detected in the test. The test is used for screening species of Neisseria, Alcaligenes, Aeromonas, Vibrio, 
Campylobacter and Pseudomonas which give positive reactions and for excluding the Enterobacteriaceae, all 
species of which give negative reactions. 
Procedure: A piece of filter paper was soaked with few drops of oxidase reagent (Whatman’s No. 1 filter paper 
impregnated with 1% tetramethyl-p-phenylene diamine dihydrochloride). Then the colony of the test organism 
was smeared on the filter paper. The positive test is indicated by the appearance of blue-purple color within 10 
seconds. 
C. Indole Production test: This test detects the ability of the organism to produce an enzyme: ‘tryptophanase’ 
which oxidizes tryptophan to form indolic metabolites: indole, skatole (methyl indole) and indole acetic acid. 
The enzyme tryptophanase catalyses the deamination reaction attacking the tryptophan molecule in its side 
chain and leaving the aromatic ring intact in the form of indole. 
Procedure: A smooth bacterial colony was stabbed on SIM (Sulphide Indole Motility) medium by a sterile stab 
wire and the inoculated media was incubated at 37°C for 24 hours. After 24 hours incubation, 2-3 drops of 
Kovac's reagent was added. Appearance of red color on the top of media indicates indole positive. Indole if 
present combines with the aldehyde present in the reagent to give a red color in the alcohol layer. The color 
reaction is based on the presence of the pyrrole structure present in indole. 
D. Methyl Red test: This test is performed to test the ability of an organism to produce and maintain stable acid 
end product from the fermentation of glucose to give a red color with the indicator methyl red and to overcome 
the buffering capacity of the system. Medium used in the study was Clark and Lubs medium (MR/VP broth, pH 
6.9). Methyl red is an indicator which is already acid and will denote changes in degree of acidity by color 
reactions over a pH range of 4.4- 6.0. 
Procedure: A pure colony of the test organism was inoculated into 2 ml of MRVP medium and was incubated 
at 37°C for 24 hours. After incubation, about 5 drops of methyl red reagent was added and mixed well. The 
positive test was indicated by the development of bright red color, indicating acidity and negative with yellow 
color. 
E.  Voges-Proskauer (VP) test: The principle of this test is to determine the ability of some organisms to 
produce a acetyl methyl carbinol, a neutral end product (acetoin) or its reduction product 2, 3-butanidiol during 
fermentation of carbohydrates. An organism of the Enterobacteriaceae group is usually either methyl red 
positive and Voges- proskauer- negative or methyl red negative and Voges-Proskauer positive. The Voges 
proskauer test for acetoin is used primarily to separate E. coli from Klebsiella and Enterobacter species. 
Procedure: A pure colony of the test organism was inoculated into 2 ml of MRVP medium and was incubated 
at 37°C for 24 hours. After incubation, about 5 drops of Barritt's reagent was added and shaken well for 
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maximum aeration and kept for 15 minutes, positive test is indicated by the development of pink red color. 
F. Citrate Utilization test: This test is performed to detect whether an organism utilizes citrate as a sole source 
of carbon for metabolism with resulting alkalinity. The medium used for citrate fermentation (Simmon’s Citrate 
medium) also contains inorganic ammonium salts. Organisms capable of utilizing citrate as its sole carbon 
source also utilizes the ammonium salts present in the medium as its sole nitrogen source, the ammonium salts 
are broken down to ammonia with resulting alkalinity. 
Procedure: A loopful of test organism was streaked on the slant area of Simmon's Citrate Agar medium and 
incubated at 37°C for 24 hours. A positive test was indicated by the growth of organism and change of media by 
green to blue, due to alkaline reaction. The pH indicator bromothymol blue has a pH range of 6.0-7.6, i.e. above 
pH 7.6; a blue color develops due to alkalinity of the medium. 
G. Motility test: This test is done to determine if an organism was motile or non-motile. Bacteria are motile by 
means of flagella. Flagella occur primarily among the bacilli; however a few cocci forms are motile .Motile 
bacteria may contain a single flagella. The motility media used for motility test are semisolid, making motility 
interpretations macroscopic. 
Procedure: Motility of organism was tested by hanging drop and cultural method. In cultural method, the test 
organism was stabbed in the SIM medium and incubated at 37ºC for 48 hours. Motile organisms migrate from 
the stabline and diffuse into the medium causing turbidity. Whereas non-motile bacteria show the growth along 
the stabline, and the surrounding media remains colorless and clear. 
H. Triple Sugar Iron (TSI) Agar Test: The TSI agar is used to determine the ability of an organism to utilize 
specific carbohydrate incorporated in the medium (glucose, sucrose and lactose in concentrations of 0.1%, 1.0% 
and 1.0% respectively), with or without the production of gas (indicated by cracks in the media as well as an air 
gap at the bottom of the tube) along with determination of possible hydrogen sulfide production (detected by 
production of black color in the medium). A pH indicator (phenol red) included in the medium can detect acid 
production from fermentation of these carbohydrates and it gives yellow reaction at acidic pH, and red reaction 
to indicate an alkaline surrounding. 
Procedure: The test organism was streaked and stabbed on the surface of TSI and incubated at 37°C for 24 
hours .Acid production limited only to the butt region of the tube is indicative of glucose utilization, while acid 
production in slant and butt indicates sucrose or lactose fermentation. The results are interpreted as follows: 
      a. Yellow (Acid)/ Yellow (Acid), Gas, H2S → Lactose/ Sucrose fermenter, H2S producer. 
       b. Red (Alkaline) / Yellow (Acid), No Gas, No H2S → Only Glucose, not lactose/ Sucrose fermenter, not 
aerogenic, No H2S production.   
    c. Red (Alkaline) / No Change →   Glucose, Lactose and Sucrose non-fermenter. 
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    d. Yellow (Acid)/ No Change → Glucose- Oxidiser. 
    e. No Change / No Change →Non-fermenter. 
I. Urea Hydrolysis test: This test demonstrates the urease activity present in certain bacteria which decomposes 
urea, releasing ammonia and carbon dioxide. Ammonia thus produced changes the color of indicator (phenol 
red) incorporated in the medium. 
Procedure: The test organism was inoculated in a medium containing urea and the indicator phenol red. The 
inoculated medium was incubated at 37°C overnight. Positive organism shows pink red color due to the 
breakdown of urea to ammonia. With the release of ammonia the medium becomes alkaline as shown by a 
change in color of the indicator to pink. 
J. Coagulase test: This test is used specifically to differentiate species within the genus Staphylococcus: S. 
aureus (usually positive) from S. saprophyticus, S epidermidis (negative). A positive coagulase test is usually 
the final diagnostic criterion for the identification of S. aureus. Free coagulase and bound coagulase are the two 
types of coagulase possessed by this organism; most strains possess both free and bound coagulase. 
Slide Coagulase Test: Bound coagulase (Clumping Factor) is detected by slide test. The bound coagulase is 
bound to the bacterial cell wall and reacts directly with fibrinogen. This results in alteration of fibrinogen so that 
it precipitates on the staphylococcal cell, causing the cells to clump when a bacterial suspension is mixed with 
plasma.  
Procedure: For slide coagulase test, a drop of physiological saline was placed on three places of a slide, and 
then a colony of the test organism was emulsified in two of the drops to make thick suspensions. Later a drop of 
plasma was added to one of the suspensions and mixed gently. Then a clumping was observed within 10 
seconds for the positive coagulase test. No plasma was added in second suspension. This was used for the 
differentiation of any granular appearance of the organism from true coagulase clumping. The third drop of 
saline was used for a known strain of coagulase positive staphylococci. 
Tube Coagulase Test: This test is carried out to detect production of free coagulase. Plasma contains coagulase 
reacting factor (CRF) which activates free coagulase. The activated coagulase acts upon prothrombin thus 
converting it to thrombin. Thrombin converts fibrinogen into fibrin which is detected as a firm gel (clot) in the 
tube test. Tube test is performed when negative or doubtful results are obtained in slide coagulase test. 
Procedure: In the tube coagulase test, plasma was diluted 1:10 in physiological saline. Four small tubes were 
taken, one for test organism, one for positive control, one for negative control, and one to observe self clotting 
of plasma. Then 0.5 ml of the diluted plasma was pipetted into each tube and 0.5 ml of test organism, 0.5 ml of 
positive control (S. aureus culture), and 0.5 ml negative control (S. epidermidis culture) was added to three 
tubes, to the fourth tube, 0.5 ml sterile broth was added. After mixing gently, all tubes were incubated at 370C 
on a water bath for 6 hours and observed for gel formation in every 30 minutes. The clotting is observed by 
gently tilting the tube for positive coagulase test. 
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APPENDIX IV 
Inhibitor Potentiated Disk diffusion (IPDD) Test/ Combined Disk Assay for ESBL confirmation using 
MASTDISCSTM ID Extended Spectrum beta- lactsmase (ESBL) Detection Discs 
ESBL production was confirmed among the suscepted bacterial strain according to the guidelines of CLSI 
(Clinical and Laboratory Standard Institute) for phenotypic confirmatory testing. According to these guidelines, 
when confirming ESBL production among the suscepts using Combined Disk (CD) assay, an increase in zone 
size of ≥ 5mm from either of the combination disk i.e. clavulanate containing disk indicates the presence of 
ESBL in the test organism.The suspected organism was inoculated into Muller hinton broth and incubated at 
370C until the turbidity matched 0.5 Mc farland standard. Using a sterile cotton swab the test organism was 
carpet cultured on a MHA plate. 
1) With the help of sterile forcep, the ESBL detection disc were placed onto the inoculated medium ensuring 
that they are evenly placed. 
2) The plate was incubated at 35-370C for 18-24 hours and the results interpreted.   
3) Interpretation of the results: we compare the zone of inhibition for the ceftazidime and cefpime disc to that 
of the ceftazidime, and cefepime plus clavulanic acid combination dics. An increase in zone diameter of ≥ 5 
mm in the presence of clavulanic acid from any or all of the discs indicates the presence of ESBL in the test 
organism. 
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